• 1.

    Choukroun G, et al.. Incidence and management of anemia in renal transplantation: an observational-French study. Nephrol Ther 2008; 4:575583.

  • 2.

    Molnar MZ, et al.. Prevalence and management of anaemia in renal transplant recipients: data from ten European centres. Nephron Clin Pract 2011; 117:c127c134.

    • Crossref
    • Search Google Scholar
    • Export Citation
  • 3.

    Vanrenterghem Y, et al.. Prevalence and management of anemia in renal transplant recipients: a European survey. Am J Transplant 2003; 3:835845.

    • Crossref
    • Search Google Scholar
    • Export Citation
  • 4.

    Awan AA, et al.. Trends in the causes of death among kidney transplant recipients in the United States (1996–2014). Am J Nephrol 2018; 48:472481.

  • 5.

    Imoagene-Oyedeji AE, et al.. Posttransplantation anemia at 12 months in kidney recipients treated with mycophenolate mofetil: risk factors and implications for mortality. J Am Soc Nephrol 2006; 17:32403247.

    • Crossref
    • Search Google Scholar
    • Export Citation
  • 6.

    Kamar N, Rostaing L. Negative impact of one-year anemia on long-term patient and graft survival in kidney transplant patients receiving calcineurin inhibitors and mycophenolate mofetil. Transplantation 2008; 85:11201124.

    • Crossref
    • Search Google Scholar
    • Export Citation
  • 7.

    Molnar MZ, et al.. Anemia is associated with mortality in kidney-transplanted patients: a prospective cohort study. Am J Transplant 2007; 7:818824.

    • Crossref
    • Search Google Scholar
    • Export Citation
  • 8.

    Winkelmayer WC, et al.. A prospective study of anaemia and long-term outcomes in kidney transplant recipients. Nephrol Dial Transplant 2006; 21:35593566.

    • Crossref
    • Search Google Scholar
    • Export Citation
  • 9.

    Winkelmayer WC, et al.. Percentage of hypochromic red blood cells is an independent risk factor for mortality in kidney transplant recipients. Am J Transplant 2004; 4:20752081.

    • Crossref
    • Search Google Scholar
    • Export Citation
  • 10.

    Kawada N, et al.. Negative effects of anemia on quality of life and its improvement by complete correction of anemia by administration of recombinant human erythropoietin in posttransplant patients. Clin Exp Nephrol 2009; 13:355360.

    • Crossref
    • Search Google Scholar
    • Export Citation
  • 11.

    Mix TC, et al.. Anemia: a continuing problem following kidney transplantation. Am J Transplant 2003; 3:14261433.

  • 12.

    Kamar N, et al.. Impact of post-transplant anemia on patient and graft survival rates after kidney transplantation: a meta-analysis. Clin Transplant 2012; 26:461469.

    • Crossref
    • Search Google Scholar
    • Export Citation
  • 13.

    Cassis P, et al.. Erythropoietin, but not the correction of anemia alone, protects from chronic kidney allograft injury. Kidney Int 2012; 81:903918.

  • 14.

    Diskin CJ, et al.. Beyond anemia: the clinical impact of the physiologic effects of erythropoietin. Semin Dial 2008; 21:447454.

  • 15.

    Purroy C, et al.. Erythropoietin receptor-mediated molecular crosstalk promotes T cell immunoregulation and transplant survival. J Am Soc Nephrol 2017; 28:23772392.

    • Crossref
    • Search Google Scholar
    • Export Citation
  • 16.

    Drueke TB, et al.. Normalization of hemoglobin level in patients with chronic kidney disease and anemia. N Engl J Med 2006; 355:20712084.

  • 17.

    Singh AK, et al.. Correction of anemia with epoetin alfa in chronic kidney disease. N Engl J Med 2006; 355:20852098.

  • 18.

    Pfeffer MA, et al.. A trial of darbepoetin alfa in type 2 diabetes and chronic kidney disease. N Engl J Med 2009; 361:20192032.

  • 19.

    Besarab A, et al.. The effects of normal as compared with low hematocrit values in patients with cardiac disease who are receiving hemodialysis and epoetin. N Engl J Med 1998; 339:584590.

    • Crossref
    • Search Google Scholar
    • Export Citation
  • 20.

    KDOQI, National Kidney Foundation. IV. Clinical practice recommendations for anemia in chronic kidney disease in transplant recipients. Am J Kidney Dis 2006; 47:S109S116.

    • Search Google Scholar
    • Export Citation
  • 21.

    Kasiske BL, et al.. KDIGO clinical practice guideline for the care of kidney transplant recipients: a summary. Kidney Int 2010; 77:299311.

  • 22.

    Heinze G, et al.. Mortality in renal transplant recipients given erythropoietins to increase haemoglobin concentration: cohort study. BMJ 2009; 339:b4018.

  • 23.

    Choukroun G, et al.. Correction of postkidney transplant anemia reduces progression of allograft nephropathy. J Am Soc Nephrol 2012; 23:360368.

  • 24.

    Tsujita M, et al.. The effect of maintaining high hemoglobin levels on long-term kidney function in kidney transplant recipients: a randomized controlled trial [published online ahead of print Dec 17, 2017]. Nephrol Dial Transplant doi: 10.1093/ndt/gfy365.

    • Search Google Scholar
    • Export Citation

Anemia Management and Outcomes in Kidney Transplant Recipients

  • 1 Ahmed A. Awan, MD, Wolfgang C. Winkelmayer, MD, ScD, and Bhamidapati V. Murthy, MD, are affiliated with the Selzman Institute for Kidney Health, Section of Nephrology, Department of Medicine, Baylor College of Medicine.
Restricted access
Save